Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
eupolicy.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
This Mastodon server is a friendly and respectful discussion space for people working in areas related to EU policy. When you request to create an account, please tell us something about you.

Administered by:

Server stats:

236
active users

eupolicy.social: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.6

#consumer

14 posts14 participants0 posts today
Public
ProPublica

The Glenmark drug recalls cover a wide range of commonly prescribed medicines — including ones that treat epilepsy, diabetes, multiple sclerosis, heart disease and high blood pressure.

Check the full list:
propublica.org/article/glenmar

ProPublicaAn Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
More from ProPublica
#News#FDA#Pharma
Continued thread
Public
Nonilex

Ahead of Fri’s court hearing on Thur’s #job cuts at the #CFPB, the #union repping the bureau’s staff countered w/their own legal filings that said the #MassFiring would make it impossible to perform the agency’s required tasks. E.G., the agency said that it was cutting the Office #Consumer Response, which expects to handle 5M complaints this year, to 20 workers down from 149. The office’s chief of staff…said…that “the office will be incapable of performing its statutory duties”….

#law#Trump
Public
ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
—

FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there has been tied to deaths of U.S. patients.
propublica.org/article/glenmar

ProPublicaAn Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
More from ProPublica
#News#FDA#Pharma
ExploreLive feeds
About